Nautilus Biotechnology, Inc.

NAUT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$27,646$19,397$114,523$185,619
Short-Term Investments$102,247$154,021$69,948$160,110
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,933$3,419$2,738$3,493
Total Curr. Assets$132,826$176,837$187,209$349,222
Property Plant & Equip (Net)$32,332$36,901$32,566$31,860
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$76,405$90,647$129,169$16,371
Tax Assets$0$0$0$0
Other NC Assets$1,180$1,180$1,108$997
Total NC Assets$109,917$128,728$162,843$49,228
Other Assets$0$0$0$0
Total Assets$242,743$305,565$350,052$398,450
Liabilities
Payables$987$1,639$1,272$1,723
Short-Term Debt$4,097$3,538$1,991$970
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,548$3,945$3,528$3,119
Total Curr. Liab.$7,632$9,122$6,791$5,812
LT Debt$26,381$31,090$28,337$29,062
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$26,381$31,090$28,337$29,062
Other Liabilities$0$0$0$0
Cap. Leases$30,478$34,628$30,328$30,032
Total Liabilities$34,013$40,212$35,128$34,874
Equity
Pref Stock$0$0$0$0
Common Stock$13$13$12$12
Retained Earnings-$273,019-$202,239-$138,564-$80,640
AOCI$57-$255-$1,854-$184
Other Equity$481,679$467,834$455,330$444,388
Total Equity$208,730$265,353$314,924$363,576
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$242,743$305,565$350,052$398,450
Net Debt$2,832$15,231-$84,195-$155,587